ATE556134T1 - Mesenchymstammzellen und verwendungendafür - Google Patents
Mesenchymstammzellen und verwendungendafürInfo
- Publication number
- ATE556134T1 ATE556134T1 AT05725577T AT05725577T ATE556134T1 AT E556134 T1 ATE556134 T1 AT E556134T1 AT 05725577 T AT05725577 T AT 05725577T AT 05725577 T AT05725577 T AT 05725577T AT E556134 T1 ATE556134 T1 AT E556134T1
- Authority
- AT
- Austria
- Prior art keywords
- stem cells
- methods
- animal
- mesenchymal stem
- mesenchyma stem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 | |
| PCT/US2005/008506 WO2005093044A1 (en) | 2004-03-22 | 2005-03-15 | Mesenchymal stem cells and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE556134T1 true ATE556134T1 (de) | 2012-05-15 |
Family
ID=46060822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05725577T ATE556134T1 (de) | 2004-03-22 | 2005-03-15 | Mesenchymstammzellen und verwendungendafür |
Country Status (6)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (ja) |
| AT (1) | ATE556134T1 (ja) |
| CA (3) | CA2868733C (ja) |
| ES (7) | ES2645018T3 (ja) |
| HK (2) | HK1205677A1 (ja) |
| TR (1) | TR201901268T4 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298862B1 (en) * | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| TR201901268T4 (tr) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mezenkimal kök hücreleri ve bunların kullanımları. |
| EP2849765A4 (en) * | 2012-05-16 | 2015-12-02 | Univ Johns Hopkins | STEM CELLS AS INDIVIDUALIZED MATERNAL THERAPY FOR PREMATURITY PREVENTION |
| JP2016210730A (ja) * | 2015-05-08 | 2016-12-15 | 上田 実 | 医薬組成物及びその製造方法並びに医薬品 |
| CN109952371A (zh) | 2016-11-15 | 2019-06-28 | 株式会社钟化 | 包含来自胎儿附属物的间充质系干细胞的细胞群、其制备方法、以及医药组合物 |
| CN111527198A (zh) | 2017-12-28 | 2020-08-11 | 株式会社钟化 | 包含贴壁性干细胞的细胞群、其制造方法、以及医药组合物 |
| WO2020251020A1 (ja) | 2019-06-14 | 2020-12-17 | 株式会社カネカ | 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法 |
| CA3148582A1 (en) * | 2019-08-15 | 2021-02-18 | Nextcell Pharma Ab | Allogeneic composition for treatment of cns disorders |
| CN113813288B (zh) * | 2021-08-11 | 2024-02-13 | 谢岩 | 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (ja) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | ガンマ・インターフェロン組成物 |
| JPH01501792A (ja) * | 1986-03-17 | 1989-06-22 | シェリング・コーポレーション | γ型インターフェロンによる癌の治療 |
| JPH10501815A (ja) * | 1994-06-07 | 1998-02-17 | リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ | 抗原特異的ｔ細胞応答の阻害方法 |
| WO1997041208A1 (en) * | 1996-04-26 | 1997-11-06 | Case Western Reserve University | Skin regeneration using mesenchymal stem cells |
| WO2001052904A2 (en) * | 2000-01-19 | 2001-07-26 | Gill Parkash S | Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| PT1066052E (pt) * | 1998-03-18 | 2006-06-30 | Osiris Therapeutics Inc | Celulas estaminais mesenquimatosas para a prevencao e tratamento |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| US6797269B2 (en) | 1998-04-03 | 2004-09-28 | Osiris Therapeutics, Inc. | Mesenchymal stem cells as immunosuppressants |
| JP5090604B2 (ja) * | 2000-04-25 | 2012-12-05 | オシリス セラピューティクス，インコーポレイテッド | 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法 |
| DK2311869T3 (da) * | 2002-02-01 | 2013-03-18 | Merck Sharp & Dohme | Anvendelse af pattedyrcytokinrelaterede reagenser |
| JP3897343B2 (ja) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
| WO2004052177A2 (en) * | 2002-12-05 | 2004-06-24 | Case Western Reserve University | Cell-based therapies for ischemia |
| TR201901268T4 (tr) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mezenkimal kök hücreleri ve bunların kullanımları. |
| EP2298862B1 (en) * | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
-
2005
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/tr unknown
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/es active Active
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/es active Active
- 2005-03-15 ES ES14172800T patent/ES2708627T3/es active Active
- 2005-03-15 AT AT05725577T patent/ATE556134T1/de active
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/es active Active
- 2005-03-15 CA CA2868733A patent/CA2868733C/en active Active
- 2005-03-15 CA CA2934682A patent/CA2934682C/en active Active
- 2005-03-15 ES ES14172807T patent/ES2657382T5/es active Active
- 2005-03-15 ES ES05725577T patent/ES2385450T3/es active Active
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/es active Active
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/ja active Active
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/ja active Active
-
2015
- 2015-06-29 HK HK15106166.8A patent/HK1205677A1/xx unknown
- 2015-06-29 HK HK15106165.9A patent/HK1205531A1/xx unknown
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/ja active Active
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/ja active Active
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/ja active Active
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/ja active Active
-
2021
- 2021-08-30 JP JP2021140167A patent/JP7546239B2/ja active Active
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2645018T3 (es) | 2017-12-01 |
| TR201901268T4 (tr) | 2019-02-21 |
| JP7033159B2 (ja) | 2022-03-09 |
| ES2544689T3 (es) | 2015-09-02 |
| JP6114500B2 (ja) | 2017-04-12 |
| ES2708627T3 (es) | 2019-04-10 |
| ES2657382T3 (es) | 2018-03-05 |
| HK1205677A1 (en) | 2015-12-24 |
| JP2017080507A (ja) | 2017-05-18 |
| ES2657382T5 (es) | 2021-07-12 |
| JP2012176948A (ja) | 2012-09-13 |
| CA3135582A1 (en) | 2005-10-06 |
| CA2868733C (en) | 2019-12-17 |
| JP6757300B2 (ja) | 2020-09-16 |
| JP6757383B2 (ja) | 2020-09-16 |
| CA2868733A1 (en) | 2005-10-06 |
| ES2643030T3 (es) | 2017-11-21 |
| JP5997237B2 (ja) | 2016-09-28 |
| JP2015061862A (ja) | 2015-04-02 |
| CA2934682A1 (en) | 2005-10-06 |
| JP2018009002A (ja) | 2018-01-18 |
| JP2021191771A (ja) | 2021-12-16 |
| CA2934682C (en) | 2021-12-07 |
| JP2023065486A (ja) | 2023-05-12 |
| JP2020111591A (ja) | 2020-07-27 |
| JP2019014747A (ja) | 2019-01-31 |
| JP6382360B2 (ja) | 2018-08-29 |
| JP7546239B2 (ja) | 2024-09-06 |
| HK1205531A1 (en) | 2015-12-18 |
| ES2385450T3 (es) | 2012-07-25 |
| ES2643076T3 (es) | 2017-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205531A1 (en) | Mesenchymal stem cells and uses therefor | |
| EP2298861A3 (en) | Mesenchymal stem cells and uses therefor | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| WO2008116157A3 (en) | Mesenchymal stem cells and uses therefor | |
| AR061170A1 (es) | Proteinas que se unen con el factor de crecimiento de hepatocitos (hgf) | |
| AR061171A1 (es) | Proteinas de union al factor de crecimiento de hepatocitos (fch) | |
| MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
| CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| EA200971053A1 (ru) | Способы лечения кожных язв | |
| TW200732347A (en) | VEGF analogs and methods of use | |
| EA201301078A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| ECSP12012211A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| GT200500260A (es) | Amidas biciclicas como inhibidores de cinasa. | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| DE602007004615D1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| MX2010009623A (es) | Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| MX2007010484A (es) | Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2. |